Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-21-000118
Filing Date
2021-08-12
Accepted
2021-08-12 16:01:57
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20210630.htm   iXBRL 10-Q 1098444
2 EX-10.1 ex_10106302021.htm EX-10.1 108156
3 EX-31.1 exhibit311_20210630.htm EX-31.1 15479
4 EX-31.2 exhibit312_20210630.htm EX-31.2 15235
5 EX-32.1 exhibit321_20210630.htm EX-32.1 4345
6 EX-32.2 exhibit322_20210630.htm EX-32.2 4333
12 dare-20210630_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-21-000118.txt   5632483

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20210630.xsd EX-101.SCH 44314
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20210630_cal.xml EX-101.CAL 38401
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20210630_def.xml EX-101.DEF 204176
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20210630_lab.xml EX-101.LAB 505961
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20210630_pre.xml EX-101.PRE 315746
13 EXTRACTED XBRL INSTANCE DOCUMENT dare-20210630_htm.xml XML 695716
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 211167394
SIC: 2834 Pharmaceutical Preparations